Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (351-360 of 420) with videos related to

Pageof 42
Sort By:
The New England Journal of Medicine|February 21, 2024
A Phase 3 Trial of Seladelpar in Primary Biliary CholangitisGideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, et al.
Nature Immunology|February 1, 2022
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition moleculesMatteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
Hepatology (Baltimore, Md.)|September 26, 2020
DCLK1, a Putative Stem Cell Marker in Human CholangiocarcinomaLorenzo Nevi, Sabina Di Matteo, Guido Carpino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Nature Immunology|May 27, 2022
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19Rosanna Asselta, Elvezia Maria Paraboschi, Matteo Stravalaci, et al.
Gastroenterology|March 6, 2021
X Chromosome Contribution to the Genetic Architecture of Primary Biliary CholangitisRosanna Asselta, Elvezia M Paraboschi, Alessio Gerussi, et al.
Journal of Hepatology|March 8, 2021
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515)Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Pageof 42

Showing results (351-360 of 420) with videos related to

Sort By:
Pageof 42
The New England Journal of Medicine|February 21, 2024
A Phase 3 Trial of Seladelpar in Primary Biliary CholangitisGideon M Hirschfield, Christopher L Bowlus, Marlyn J Mayo, et al.
Nature Immunology|February 1, 2022
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition moleculesMatteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.
Hepatology (Baltimore, Md.)|September 26, 2020
DCLK1, a Putative Stem Cell Marker in Human CholangiocarcinomaLorenzo Nevi, Sabina Di Matteo, Guido Carpino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary CholangitisNikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Nature Immunology|May 27, 2022
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19Rosanna Asselta, Elvezia Maria Paraboschi, Matteo Stravalaci, et al.
Gastroenterology|March 6, 2021
X Chromosome Contribution to the Genetic Architecture of Primary Biliary CholangitisRosanna Asselta, Elvezia M Paraboschi, Alessio Gerussi, et al.
Journal of Hepatology|March 8, 2021
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515)Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Pageof 42